The Latest Breaking News from MHRA

Concerns over potential conflicts of interest lead to calls for regulator’s policy to be strengthened

Plans to hire 200 workers at the Livingston plant were put into question last year after Boris Johnson pulled the plug on a £1billion contract to buy 100million doses of the vaccine.

Call for pregnant women to be banned from taking drug

Former health secretary Jeremy Hunt says epilepsy drug sodium valproate ‘a major risk to patient safety’

The vaccine's rollout still depends on the verdict of the Joint Committee on Vaccination Immunisation.

A decision on whether it will be offered still has to be made

Covid-19 infections have fallen for the first time in England in six weeks but Wales remains at a record high, the latest figures show.

Here's a roundup of top developments in the biotech space over the last 24 hours:

‘Spikevax’ jab declared ‘safe and effective’ for this age group

The UK has become the first major country to approve Valneva's vaccine against covid-19

The Healthcare products Regulatory Agency (MHRA) of the U.K. has granted Conditional Marketing Authorization for Valneva SE's (NASDAQ:VALN)COVID-19 vaccine candidate, VLA2001, for primary immunization in adults 18 to 50 years of age. MHRA found that VLA2001 meets safety, quality, and effectiveness standards. This new marketing authorization comes in addition to the emergency use authorization,…